X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder caused by ABCD1 gene mutations, leading to accumulation of very long-chain fatty acids (VLCFA) and disrupted cholesterol metabolism in specific cells like oligodendrocytes and macrophages. Research on X-ALD patient-derived fibroblasts and mouse models shows increased cholesterol esters and changes in genes related to cholesterol processing, highlighting potential targets for therapeutic intervention to manage VLCFA and cholesterol levels.
Award recipients receive up to $500,000 per year over the four-year period of performance to implement activities that are aligned with the following program goals:
Address structural- and systems-level barriers to improve rural residents’ access to quality, integrated SUD and other behavioral health care services.
Improve the quality and sustainability of rural behavioral health care services by supporting rural health care providers to offer coordinated, evidence- based, trauma-informed SUD and other behavioral health care services.
Improve the capacity of the behavioral health care system to address rural community risk factors and social determinants of health that affect the behavioral health of rural residents.
Self-nominations are accepted. Nominees do not have to be members of APSA, affiliated with an institution in the United States, or an American citizen in order to be considered for an award.
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply and Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
The aggregation of amyloid beta (Aβ) peptide Aβ1−42 into plaques is central to Alzheimer's disease pathology, highlighting the need for its accessible synthesis for research. This review details the history and challenges of synthesizing Aβ1−42, from its initial creation to recent advancements, providing insights into how these developments support broader Alzheimer's disease research.
Recent research highlights that small cationic amphipathic peptides, traditionally known as antimicrobial peptides (AMPs), serve multifaceted roles not only in fighting infections but also as antibiofilm agents, immune modulators, and anti-inflammatories, leading to the adoption of the term host defense peptides (HDPs) to better reflect their diverse functions. This review critically evaluates the varied roles of HDPs in infectious diseases and inflammation, discussing the concept of chemical space and how overlapping activity landscapes might enable leveraging these peptides therapeutically.
What impact does the presence of a trained Emergency Physician with the ability to perform trans-venous cardiac pacing have on patient outcomes in emergency situations requiring temporary cardiac pacing?
How effective is iontophoresis, specifically using dexamethasone sodium phosphate, in managing oral submucous fibrosis compared to traditional intralesional injections, and what are its implications for patient comfort and treatment adherence?
When IoT expands, it holds the potential to uncover novel insights, foster new types of collaboration, and revolutionize business models across various sectors.
Very interesting paper. The authors provided new molecular insight into how a keystone bacterium in the human gut microbiota adheres to resistant starches as a prelude to their breakdown and fermentation.
The authors investigated how the intracellular pathogen Salmonella enterica activates gene expression required to counteract oxidative damage. The authors show that this bacterium utilizes host oxidative molecules to activate regulatory proteins that enhance the production of effector molecules, counteracting the host weapon NADPH oxidase and inducing a protective response.
Diptoindonesin G (dip G) has been identified as a promising HSP90 modulator that promotes degradation of oncogenic proteins, such as the estrogen receptor, without triggering the heat shock response, offering a potential new therapy for endocrine-resistant breast cancers that harbor estrogen receptor ligand-binding domain mutations. Unlike traditional endocrine therapies, dip G's mechanism of action is unaffected by mutations that confer resistance to current treatments, suggesting it could be an effective strategy against a broader range of cancer cells, including those with established mechanisms of endocrine resistance.
In this JBC paper, the authors discovered that these endoplasmic reticulum and mitochondrial proteins moved toward each other and met at the contact site between the two organelles, thereby forming a ‘bridge to death’.
The development of new protein functionalities by incorporating non-coded amino acids into biotechnological applications requires overcoming natural barriers that prevent incorrect amino acid incorporation during protein synthesis. This rapidly evolving field benefits from the discovery and design of new tools, often inspired by archaeal biology. A recent study published in JBC examines one such tool, exploring its development and uncovering surprising aspects of how the universal genetic code machinery came to be.
Article